Broken beyond repair: self regulation of industry payments to clinicians and hospitals
(2024) In BMJ: British Medical Journal 386.- Abstract
- The latest Novo Nordisk revelations provide the strongest argument yet for a Sunshine Act for drug and medical device companies operating in the UK
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/f4013f18-3873-4dcb-9f97-fdeb80756183
- author
- Ozieranski, Piotr and Mulinari, Shai LU
- organization
- publishing date
- 2024-07-12
- type
- Contribution to journal
- publication status
- published
- subject
- in
- BMJ: British Medical Journal
- volume
- 386
- article number
- q1559
- publisher
- BMJ Publishing Group
- external identifiers
-
- pmid:38997125
- ISSN
- 1756-1833
- DOI
- 10.1136/bmj.q1559
- project
- Following the money: cross-national study of pharmaceutical industry payments to medical associations and patient organisations
- language
- English
- LU publication?
- yes
- id
- f4013f18-3873-4dcb-9f97-fdeb80756183
- date added to LUP
- 2024-07-17 11:49:14
- date last changed
- 2024-07-23 15:48:30
@misc{f4013f18-3873-4dcb-9f97-fdeb80756183, abstract = {{The latest Novo Nordisk revelations provide the strongest argument yet for a Sunshine Act for drug and medical device companies operating in the UK}}, author = {{Ozieranski, Piotr and Mulinari, Shai}}, issn = {{1756-1833}}, language = {{eng}}, month = {{07}}, publisher = {{BMJ Publishing Group}}, series = {{BMJ: British Medical Journal}}, title = {{Broken beyond repair: self regulation of industry payments to clinicians and hospitals}}, url = {{http://dx.doi.org/10.1136/bmj.q1559}}, doi = {{10.1136/bmj.q1559}}, volume = {{386}}, year = {{2024}}, }